Methylene Blue in Sepsis: A Randomized Controlled Trial

Summary

The purpose of this study is to investigate whether the addition of Methylene Blue to the standard treatment of septic shock will reduce vasopressor requirements

Timeline

Start

2007-06

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped (Enrollment): “primary site withdrew due to competing study: never enrolled any subjects.”

Drugs

Indications